Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer

Stock News

Jun 29

Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.

The certificate pertains to the "Fully Automated Chemiluminescence Immunoassay Analyzer." The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.

This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of Tellgen Corporation and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1147852283"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147852283\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147852283?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 18:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147852283","market":"sh","top_or_hot":-1,"title":"Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer","media":"Stock News","content":"<p>Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.<br><br>The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.<br><br>This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of <b>Tellgen Corporation</b> and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-29 18:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.<br><br>The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.<br><br>This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of <b>Tellgen Corporation</b> and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1147852283","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147852283","pubTimestamp":1782727224,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","300642":"透景生命","BK1574":"生物医药B类股","BK0042":"基因检测","BK0239":"医药制造","BK0046":"生物疫苗","09996":"沛嘉医疗-B","BK1583":"高瓴概念","BK1100":"医疗保健设备"},"translate_title":"Tellgen Corporation子公司获得全自动化学发光免疫分析仪医疗器械注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"300642":1,"09996":1},"content_text":"Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of Tellgen Corporation and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}